Drugs / Autologous immunoglobulin
Autologous immunoglobulin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02835170 | Apr 2015 → Mar 2017 | atopic eczema | Ajou University School of Medicine | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous immunoglobulin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02835170 ↗ |
| Modality | Protein / enzyme biologic | “Autologous immunoglobulin (total IgG) aseptically purified from the autologous plasma” NCT02835170 ↗ |
| Route | Intramuscular | “administered to the patients by intramuscular injection” NCT02835170 ↗ |